• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
No Result
View All Result
Monday, February 6, 2023
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
No Result
View All Result
Alternatives Watch
No Result
View All Result

RTW Investments on the new quest for cures

Ann C. LoguebyAnn C. Logue
July 28, 2021
in Features, Hedge Funds, Manager News
RTW Investments on the new quest for cures

By ckstockphoto

ShareTweetShareSendSend

Researchers and clinicians are working miracles in medicine these days because of breakthroughs in therapies that have received crucial backing from the alternative investment industry.

There is much more work to be done, and that’s what drives the staff of RTW Investments. “This is the start of an amazing next generation of innovation,” said Stephanie Sirota, chief business officer at RTW. “You have a wonderful advantage when you start evaluating the science, before it is even investible.”

These innovations have included the rapid development of safe and effective RNA vaccines against COVID 19 and . . .

Continue Reading

Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.

Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Join Now
Annual
$300
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
Join Now

ShareTweetShareSendSend
Previous Post

Temasek leads $440 million investment round for iCapital Network

Next Post

Blue Owl closes inaugural fund at $2bn

Ann C. Logue

Ann C. Logue

Ann Logue is a writer specializing in business and finance. Her most recent book is "The Complete Idiot’s Guide: Options Trading" (Alpha 2016). She lives in Chicago.

Related Posts

CalSTRS promotes for private markets
Pensions

CalSTRS promotes for private markets

UBP partners with credit firm to widen its liquid alts platform
Hedge Funds

UBP partners with credit firm to widen its liquid alts platform

Bridgewater names Karniol-Tambour as co-CIO
Hedge Funds

Bridgewater names Karniol-Tambour as co-CIO

Citco data reveals hedge funds' Q4 fightback
Hedge Funds

Citco data reveals hedge funds’ Q4 fightback

MFA welcomes UK regulator's recognition of short selling in ESG
ESG

MFA welcomes UK regulator’s recognition of short selling in ESG

Next Post
Blue Owl closes inaugural fund at $2bn

Blue Owl closes inaugural fund at $2bn

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

CalSTRS promotes for private markets

CalSTRS promotes for private markets

Singapore's GIC partners for $15bn managed net-lease REIT deal

Singapore’s GIC partners for $15bn managed net-lease REIT deal

March Capital raises Fund IV

March Capital raises Fund IV

UBP partners with credit firm to widen its liquid alts platform

UBP partners with credit firm to widen its liquid alts platform

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research
  • Subscribe
  • Log In

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In

© 2019-2022, All Rights Reserved  |  BMV Digital

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

Cookie Consent
We do not use cookies on our website other than those that are strictly necessary for the website to function. By clicking “Accept”, you consent to the use of all six strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo